Discover
Clinical Data Talks
Clinical Data Talks
Author: CRScube
Subscribed: 3Played: 3Subscribe
Share
© Copyright 2025 All rights reserved.
Description
Clinical Data Talks is your go-to podcast for an in-depth look at the evolving world of clinical data capture, management and analysis.
Join industry experts and clinical data enthusiasts as we explore the challenges, breakthroughs and innovations shaping the industry. Through fresh perspectives, real-world experiences and forward-thinking discussions, we keep you informed on the latest trends driving the future of clinical trials.
Whether you’re a data manager, researcher or passionate about the industry, Clinical Data Talks is your trusted source for insights into the world of clinical data.
Join industry experts and clinical data enthusiasts as we explore the challenges, breakthroughs and innovations shaping the industry. Through fresh perspectives, real-world experiences and forward-thinking discussions, we keep you informed on the latest trends driving the future of clinical trials.
Whether you’re a data manager, researcher or passionate about the industry, Clinical Data Talks is your trusted source for insights into the world of clinical data.
22 Episodes
Reverse
In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Alwin van den Broek, Director of Clinical Operations at Bevinced. Together, they unpack the unique operational realities of medical device clinical trials and explore why clinician readiness and procedural precision are paramount to generating compliant, high-quality data.
With a foundation as a human movement scientist and extensive experience leading medtech clinical investigations, Alwin explains how medical device trials outcomes heavily depend on surgical technique and user execution, rather than simple drug administration. He shares why sponsor oversight must extend directly into the operating room to safeguard study integrity and prevent protocol deviations.
Sylvain and Alwin discuss how comprehensive training programs – ranging from cadaver labs and proctoring to the strategic use of "roll-in patients" – help mitigate the clinician learning curve. They also examine why sponsors must implement early on-site monitoring after initial cases and adopt a "designing backwards" mindset to capture the data needed beyond initial CE marking.
Tune in to explore how physician proficiency shapes trial endpoints, why risk mitigation belongs in the surgical suite, and how cross-functional foresight drives long-term commercial success in medtech.
In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Khaudeja Bano, an industry leader with over 25 years of experience across top pharmaceutical companies and deep expertise in diagnostics, therapeutics, and combination products. Together, they unpack compliance and safety management for combination products and examine how rapid drug-device innovation is moving healthcare directly into patients' hands.
With a distinguished background that includes serving on the working group that helped establish 21 CFR Part 4 regulations, Khaudeja shares how the rise of GLP-1 auto-injectors and drug delivery systems is redefining safety data collection. She explains why pharmaceutical sponsors must take holistic ownership of safety, efficacy, and risk management across the entire product – from evaluating human factors and needle protection to feeding real-world usability data back into next-generation device design.
Sylvain and Khaudeja discuss the nuances of global regulatory frameworks across the US FDA, EMA, and PMDA, why the controlled environment of clinical trials offers an ideal setting to listen to the patient voice, and how bringing technology partners directly to the regulatory table creates smoother compliance workflows.
Tune in to explore how combination products are reshaping safety surveillance, cross-industry collaboration, and the future of patient-centered healthcare.
Sylvain Berthelot welcomes Craig Mooney to the podcast, Founder and Principal Consultant at IRT Advisors Group. Together, they unpack the trade-offs between standalone point solutions and unified eClinical platforms, exploring how sponsor growth shapes technology choices in clinical trials.
With over three decades of clinical trial experience, Craig shares insights from his article Choose Your Hard, explaining why there is no single "right" answer when selecting trial software.
He and Sylvain discuss the context that may lead CROs and sponsors to choose specialized point solutions instead of integrated platforms. They also address the hidden operational costs of data reconciliation, why discrepancies like visit dates versus transaction dates are often misunderstood, and how unified platform architectures can eliminate artificial data friction.
Tune in to explore how organizational scale, system design, and decision-making structures impact the future of clinical trial technology.
In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Vivienne van de Walle, founder of PT&R, an independent clinical site she has successfully led for nearly 30 years. Together, they explore what it takes to make clinical sites truly want to participate in clinical trials and how site-level challenges impact the broader research ecosystem.
Drawing on decades of on-the-ground experience, Vivienne highlights the growing operational burden placed on sites and patients due to technology overload and complex study protocols. From the alarming rate of "once-and-done" investigators dropping out after their first trial to Clinical Research Coordinators drowning in standalone systems, she sheds light on how software complexity drives talent out of the industry while taking time away from direct patient care.
Sylvain and Vivienne discuss why true patient centricity requires reducing trial burden rather than just collecting more data, how consulting sites early in study design prevents costly protocol deviations, and why rushing trial setup timelines creates severe downstream friction for site operations.
Tune in to explore how sponsors can foster better collaboration with sites, simplify digital workflows, and create a more sustainable environment for clinicians, site staff, and patients alike.
Sylvain Berthelot welcomes Claudia Rodriguez, CEO of RARAS, a CRO specialized in conducting research across Latin America. Together, they explore the untapped potential of this diverse region and why it is increasingly becoming a strategic priority for global sponsors.
With a deep passion for the Latin American market, Claudia dispels common myths about the region's accessibility and infrastructure. She shares how the landscape is shifting from a traditional focus on Phase 3 "rescue" trials toward early-phase research, driven by geopolitical changes and a growing need for diverse genetic data.
Sylvain and Claudia discuss the nuances of different markets, from Chile's rapid regulatory timelines for medical devices to Brazil's world-renowned Key Opinion Leaders. They also delve into the unique cultural bond between patients and physicians in the region, which results in remarkably high retention rates.
Tune in to our Season 3 finale to discover how strategic planning in Latin America can accelerate regulatory approval, provide a "soft landing" for future product launches, and ensure high-quality data that meets the rigorous standards of the FDA and EMA.








